|Bid||660.00 x 800|
|Ask||675.00 x 800|
|Day's Range||652.03 - 670.96|
|52 Week Range||492.13 - 747.42|
|Beta (5Y Monthly)||0.21|
|PE Ratio (TTM)||10.68|
|Earnings Date||Feb 03, 2022 - Feb 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||702.05|
Regeneron, Vertex, Intercept Pharmaceuticals, and Biohaven Pharmaceutical are part of Zacks top Analyst Blog
Earnings and regulatory updates from Regeneron (REGN) and Vertex (VRTX) are a few key highlights from the biotech sector during the past week.
It is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent performance, when its stock...